Spread of SARS-CoV-2 in the Icelandic Population

被引:811
|
作者
Gudbjartsson, Daniel F. [1 ,2 ]
Helgason, Agnar [1 ,3 ]
Jonsson, Hakon [1 ]
Magnusson, Olafur T. [1 ]
Melsted, Pall [1 ,2 ]
Norddahl, Gudmundur L. [1 ]
Saemundsdottir, Jona [1 ]
Sigurdsson, Asgeir [1 ]
Sulem, Patrick [1 ]
Agustsdottir, Arna B. [1 ]
Eiriksdottir, Berglind [1 ]
Fridriksdottir, Run [1 ]
Gardarsdottir, Elisabet E. [1 ]
Georgsson, Gudmundur [1 ]
Gretarsdottir, Olafia S. [6 ]
Gudmundsson, Kjartan R. [1 ]
Gunnarsdottir, Thora R. [6 ]
Gylfason, Arnaldur [1 ]
Holm, Hilma [1 ]
Jensson, Brynjar O. [1 ]
Jonasdottir, Aslaug [1 ]
Jonsson, Frosti [1 ]
Josefsdottir, Kamilla S. [7 ]
Kristjansson, Thordur [1 ]
Magnusdottir, Droplaug N. [1 ]
le Roux, Louise [1 ]
Sigmundsdottir, Gudrun [7 ]
Sveinbjornsson, Gardar [1 ]
Sveinsdottir, Kristin E. [1 ]
Sveinsdottir, Maney [6 ]
Thorarensen, Emil A. [1 ]
Thorbjornsson, Bjarni [1 ]
Loeve, Arthur [4 ,6 ]
Masson, Gisli [1 ]
Jonsdottir, Ingileif [1 ,4 ]
Moeller, Alma D. [7 ]
Gudnason, Thorolfur [7 ]
Kristinsson, Karl G. [4 ,5 ,6 ]
Thorsteinsdottir, Unnur [1 ,4 ]
Stefansson, Kari [1 ,4 ]
机构
[1] deCODE Genet Amgen, Sturlugata 8, IS-102 Reykjavik, Iceland
[2] Univ Iceland, Sch Engn & Nat Sci, Reykjavik, Iceland
[3] Univ Iceland, Dept Anthropol, Reykjavik, Iceland
[4] Univ Iceland, Fac Med, Sch Hlth Sci, Reykjavik, Iceland
[5] Univ Iceland, Biomed Ctr, Reykjavik, Iceland
[6] Landspitali Nat Univ Hosp, Dept Clin Microbiol, Reykjavik, Iceland
[7] Directorate Hlth, Reykjavik, Iceland
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2020年 / 382卷 / 24期
关键词
CORONAVIRUS;
D O I
10.1056/NEJMoa2006100
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background During the current worldwide pandemic, coronavirus disease 2019 (Covid-19) was first diagnosed in Iceland at the end of February. However, data are limited on how SARS-CoV-2, the virus that causes Covid-19, enters and spreads in a population. Methods We targeted testing to persons living in Iceland who were at high risk for infection (mainly those who were symptomatic, had recently traveled to high-risk countries, or had contact with infected persons). We also carried out population screening using two strategies: issuing an open invitation to 10,797 persons and sending random invitations to 2283 persons. We sequenced SARS-CoV-2 from 643 samples. Results As of April 4, a total of 1221 of 9199 persons (13.3%) who were recruited for targeted testing had positive results for infection with SARS-CoV-2. Of those tested in the general population, 87 (0.8%) in the open-invitation screening and 13 (0.6%) in the random-population screening tested positive for the virus. In total, 6% of the population was screened. Most persons in the targeted-testing group who received positive tests early in the study had recently traveled internationally, in contrast to those who tested positive later in the study. Children under 10 years of age were less likely to receive a positive result than were persons 10 years of age or older, with percentages of 6.7% and 13.7%, respectively, for targeted testing; in the population screening, no child under 10 years of age had a positive result, as compared with 0.8% of those 10 years of age or older. Fewer females than males received positive results both in targeted testing (11.0% vs. 16.7%) and in population screening (0.6% vs. 0.9%). The haplotypes of the sequenced SARS-CoV-2 viruses were diverse and changed over time. The percentage of infected participants that was determined through population screening remained stable for the 20-day duration of screening. Conclusions In a population-based study in Iceland, children under 10 years of age and females had a lower incidence of SARS-CoV-2 infection than adolescents or adults and males. The proportion of infected persons identified through population screening did not change substantially during the screening period, which was consistent with a beneficial effect of containment efforts.
引用
收藏
页码:2302 / 2315
页数:14
相关论文
共 50 条
  • [1] Early Spread of SARS-CoV-2 in the Icelandic Population
    Cowie, Benjamin C.
    MacLachlan, Jennifer H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (22): : 2184 - 2184
  • [2] Spread of SARS-CoV-2
    Stower, Hannah
    [J]. NATURE MEDICINE, 2020, 26 (04) : 465 - 465
  • [3] Spread of SARS-CoV-2
    Hannah Stower
    [J]. Nature Medicine, 2020, 26 : 465 - 465
  • [4] Nowcasting the spread of SARS-CoV-2
    Rossman, Hagai
    Segal, Eran
    [J]. NATURE MICROBIOLOGY, 2022, 7 (01) : 16 - 17
  • [5] The engines of SARS-CoV-2 spread
    Lee, Elizabeth C.
    Wada, Nikolas I.
    Grabowski, M. Kate
    Gurley, Emily S.
    Lessler, Justin
    [J]. SCIENCE, 2020, 370 (6515) : 406 - 407
  • [6] Invisible spread of SARS-CoV-2
    Xiong, Nian
    Wang, Tao
    Lin, Zhicheng
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1011 - 1012
  • [7] Nowcasting the spread of SARS-CoV-2
    Hagai Rossman
    Eran Segal
    [J]. Nature Microbiology, 2022, 7 : 16 - 17
  • [8] SARS-CoV-2 HaploGraph: visualization of SARS-CoV-2 haplotype spread in Japan
    Nakagawa, So
    Katayama, Toshiaki
    Jin, Lihua
    Wu, Jiaqi
    Kryukov, Kirill
    Oyachi, Rise
    Takeuchi, Junko S.
    Fujisawa, Takatomo
    Asano, Satomi
    Komatsu, Momoka
    Onami, Jun-ichi
    Abe, Takashi
    Arita, Masanori
    [J]. GENES & GENETIC SYSTEMS, 2023, 98 (05) : 221 - 237
  • [9] The spread rate of SARS-CoV-2 is strongly associated with population density
    Chen, Ke
    Li, Zhenghao
    [J]. JOURNAL OF TRAVEL MEDICINE, 2020, 27 (08)
  • [10] Invisible spread of SARS-CoV-2 Reply
    Kucharski, Adam J.
    Eggo, Rosalind M.
    [J]. LANCET INFECTIOUS DISEASES, 2020, 20 (09): : 1012 - 1012